Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES — Stella

Home/Diastolic Dysfunction/Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

View on ClinicalTrials.gov

Recruiting

Back to Diastolic Dysfunction trials

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Texas Tech University Health Sciences Center (TTUHSC), Lubbock, Texas

Key details

Phase

Early testing / Safety & dosing

Sponsor

Texas Tech University Health Sciences Center

Enrollment target

~200 participants

Started

July 2022

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

60 Years – 80 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.